Ex-CEO Admits Securities Fraud In Fake COVID Test Case
A former biotech CEO pled guilty in D.C. federal court Thursday to charges of securities fraud, wire fraud and obstruction after he concocted a scheme to defraud investors by falsely telling...To view the full article, register now.
Already a subscriber? Click here to view full article